Publikationsliste der Abteilung

2009

A scale for decision making between whole lung transplantation or lobar transplantation.

Loizzi D, Aigner C, Jaksch P, Scheed A, Mora B, Sollitto F, Klepetko W.

Eur J Cardiothorac Surg. 2009 Dec 30.

Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD.

Hacker S, Lambers C, Pollreisz A, Hoetzenecker K, Lichtenauer M, Mangold A, Niederpold T, Hacker A, Lang G, Dworschak M, Vukovich T, Gerner C, Klepetko W, Ankersmit HJ.

J Clin Lab Anal. 2009;23(6):372-9.

SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis.

Jayachandran A, Königshoff M, Yu H, Rupniewska E, Hecker M, Klepetko W, Seeger W, Eickelberg O.

Thorax. 2009 Dec;64(12):1053-61.

Guidelines for the diagnosis and treatment of pulmonary hypertension.

Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G.

Eur Respir J. 2009 Dec;34(6):1219-63.

Antivascular agents for non-small-cell lung cancer: current status and future directions.

Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B.

Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86.

Levels of sCD40, sCD 40L, TNFα, and TNF-RI in the Culprit Coronary Artery During Myodardial Infarction.

Hoetzenecker K, Adlbrecht C, Lichtenauer M, Hacker S, Hoetzenecker W, Mangold A, Nickl S, Mitterbauer A, Zimmermann A, Lang I, Klepetko W,  Ankersmit HJ.

Labmedicine 2009 Nov; 40(11): 5-9.

Extended videoscopic robotic thymectomy with the da Vinci telemanipulator for the treatment of myasthenia gravis: the Vienna experience.

Fleck T, Fleck M, Müller M, Hager H, Klepetko W, Wolner E, Wisser W.

Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):784-7.

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors/Task Force Members, Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG), Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P; Document Reviewers, Sechtem U, Al Attar N, Andreotti F, Aschermann M, Asteggiano R, Benza R, Berger R, Bonnet D, Delcroix M, Howard L, Kitsiou AN, Lang I, Maggioni A, Nielsen-Kudsk JE, Park M, Perrone-Filardi P, Price S, Domenech MT, Vonk-Noordegraaf A, Zamorano JL.

Eur Heart J. 2009 Oct;30(20):2493-537.

Current treatment paradigms of superior sulcus tumours.

Tamura M, Hoda MA, Klepetko W.

Eur J Cardiothorac Surg. 2009 Oct;36(4):747-53.

Evaluation of interleukin-6 and interleukin-10 in lung transplant patients with human cytomegalovirus infection.

Zedtwitz-Liebenstein K, Jaksch P, Burgmann H, Friehs H, Hofbauer R, Schellongowski P, Frass M.

Clin Transplant. 2009 Sep-Oct;23(5):687-91.

Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.

Jaksch P, Zweytick B, Kerschner H, Hoda AM, Keplinger M, Lang G, Aigner C, Klepetko W.

J Heart Lung Transplant. 2009 Jul;28(7):670-5.

Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival.

Kerschner H, Jaksch P, Karigl G, Popow-Kraupp T, Klepetko W, Puchhammer-Stöckl E.

Transplantation. 2009 Jun 15;87(11):1720-6.

Prolonged venoarterial extracorporeal membrane oxygenation after transplantation restores functional integrity of severely injured lung allografts and prevents the development of pulmonary graft failure in a pig model.

Lang G, Aigner C, Winkler G, Shkirdladze K, Wisser W, Dekan G, Tamura M, Heinze G, Van Raemdonck D, Klepetko W.

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1493-8.

Alpha-Gal specific IgG immune response after implantation of bioprostheses.

Mangold A, Szerafin T, Hoetzenecker K, Hacker S, Lichtenauer M, Niederpold T, Nickl S, Dworschak M, Blumer R, Auer J, Ankersmit HJ.

Thorac Cardiovasc Surg. 2009 Jun;57(4):191-5.

Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium.

Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, Wolfsberger M, Gerner C, Hacker S, Mildner M, Moser B, Lichtenauer M, Podesser BK.

Eur J Clin Invest. 2009 Jun;39(6):445-56.

MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study.

Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG.

Scand J Gastroenterol. 2009;44(6):745-51.

Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction.

Hacker S, Lambers C, Hoetzenecker K, Pollreisz A, Aigner C, Lichtenauer M, Mangold A, Niederpold T, Zimmermann M, Taghavi S, Klepetko W, Ankersmit HJ.

Clin Lab. 2009;55(1-2):31-40.

Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.

Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG.

Dig Liver Dis. 2009 Jun;41(6):417-23.

The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension.

Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S, Stein MM, Bohle RM, Klepetko W, Hoda MA, Schermuly RT, Grimminger F, Seeger W, Voswinckel R.

Am J Respir Cell Mol Biol. 2009 Jun;40(6):683-91.

Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report.

Hoetzenecker K, Ankersmit HJ, Bonderman D, Hoetzenecker W, Seitelberger R, Klepetko W, Lang IM.

J Thorac Cardiovasc Surg. 2009 Mar;137(3):760-1.

High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.

Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.

Clin Cancer Res. 2009 Mar 1;15(5):1741-6.

T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.

Lambers C, Hacker S, Posch M, Hoetzenecker K, Pollreisz A, Lichtenauer M, Klepetko W, Ankersmit HJ.

Clin Exp Immunol. 2009 Mar;155(3):466-75.

Update on chronic thromboembolic pulmonary hypertension, a frequently undiagnosed condition.

Lang IM, Klepetko W.

Rev Esp Cardiol. 2009 Feb;62(2):120-5.

Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery.

Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, Lichtenauer M, Dworschak M, Wolner E, Ankersmit HJ.

Thorac Cardiovasc Surg. 2009 Feb;57(1):25-9.

Combined cervicothoracic approaches for complex mediastinal masses.

Aigner C, Hoda MA, Klepetko W.

Thorac Surg Clin. 2009 Feb;19(1):107-12.

Cerebral desaturation during cardiac arrest: its relation to arrest duration and left ventricular pump function.

Skhirtladze K, Birkenberg B, Mora B, Moritz A, Ince I, Ankersmit HJ, Steinlechner B, Dworschak M.

Crit Care Med. 2009 Feb;37(2):471-5.

Consequences of a wait-and-see strategy for benign metastasizing leiomyomatosis of the lung.

Hoetzenecker K, Ankersmit HJ, Aigner C, Lichtenauer M, Kreuzer S, Hacker S, Hoetzenecker W, Lang G, Klepetko W.

Ann Thorac Surg. 2009 Feb;87(2):613-4.

Risk factors for chronic thromboembolic pulmonary hypertension.

Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM.

Eur Respir J. 2009 Feb;33(2):325-31.

Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.

Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J.

Crit Rev Oncol Hematol. 2009 Feb;69(2):108-24.

Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study.

Skoro-Sajer N, Hack N, Sadushi-Koliçi R, Bonderman D, Jakowitsch J, Klepetko W, Hoda MA, Kneussl MP, Fedullo P, Lang IM.

Circulation. 2009 Jan 20;119(2):298-305.